Oct 31, 2025 03:36AM Oppenheimer Reiterates Outperform Rating on MindMed (MNMD)

Oct 13, 2025 05:50AM Needham Starts MindMed (MNMD) at Buy

Sep 10, 2025 09:16AM RBC Capital on Biotech: 'Who Wins and Who Loses If RFK, Jr. Goes'

Sep 4, 2025 11:05AM JAMA publishes positive LSD study results for anxiety treatment

Aug 4, 2025 03:09AM Oppenheimer Resumes MindMed (MNMD) at Outperform

Jul 31, 2025 04:07PM Mind Medicine (MNMD) Misses Q2 EPS by 13c

Jul 16, 2025 10:54AM Mind Medicine (MNMD) stock rises as lawmakers discuss psychedelic therapy for veterans

Jun 18, 2025 03:32PM Mind Medicine (MNMD) short duration calls expiring on Friday active as share price up 5.8%

May 29, 2025 08:04AM Cantor Fitzgerald Reiterates Overweight Rating on MindMed (MNMD)

May 27, 2025 07:02AM Mind Medicine (MNMD) Appoints Brandi Roberts as CFO

May 8, 2025 07:08AM Mind Medicine (MNMD) Misses Q1 EPS by 1c

Apr 16, 2025 07:16AM Oppenheimer Reiterates Outperform Rating on MindMed (MNMD)

Apr 15, 2025 07:06AM MindMed (MNMD) Announces First Patient Dosed in Phase 3 Emerge Study of MM120 in Major Depressive Disorder (MDD)

Mar 17, 2025 07:02AM Mind Medicine (MNMD) Appoints Matt Wiley as Chief Commercial Officer

Mar 7, 2025 06:44AM H.C. Wainwright Reiterates Buy Rating on MindMed (MNMD)

Mar 6, 2025 07:01AM Mind Medicine (MNMD) Misses Q4 EPS by 10c

Feb 5, 2025 02:42PM Mind Medicine (MNMD) sees mid-day gains

Jan 30, 2025 07:03AM MindMed (MNMD) Announces First Patient Dosed in Panorama, the Second Pivotal Phase 3 Study of MM120 in Generalized Anxiety Disorder

Jan 28, 2025 06:34AM Evercore ISI Starts MindMed (MNMD) at Outperform

Jan 13, 2025 12:50PM RBC Capital Explores Biotech Implications Following Cavazzoni's Departure from the FDA

Dec 19, 2024 07:05AM MindMed (MNMD) to Be Added to the Nasdaq Biotechnology Index

Dec 5, 2024 07:02AM Mind Medicine (MNMD) Awarded Innovation Passport Designation by the United Kingdom (UK) Innovative Licensing and Access Pathway (ILAP) Steering Group for MM120 Orally Disintegrating Tablet (ODT) for G

Dec 3, 2024 07:01AM Mind Medicine (MNMD) Appoints Javier Muniz as VP of Research and Development Strategy

Nov 18, 2024 07:03AM Mind Medicine (MNMD) Appoints Gregg Pratt as Chief Regulatory and Quality Assurance Officer

Nov 7, 2024 04:19PM Mind Medicine (MNMD) Tops Q3 EPS by 1c

Sep 16, 2024 08:08AM MindMed (MNMD) PT Lowered to $14 at Canaccord Genuity

Aug 29, 2024 06:40AM MindMed (MNMD) PT Raised to $55 at H.C. Wainwright

Aug 13, 2024 07:03AM Mind Medicine (MNMD) Tops Q2 EPS by 7c

Aug 9, 2024 08:45AM Mind Medicine (MNMD) Prices 9.29M Share Offering at $7/sh

Aug 9, 2024 06:18AM Mind Medicine (MNMD) Announces Proposed Share Offering

Jul 24, 2024 05:11AM Roth/MKM Starts MindMed (MNMD) at Buy

Jul 17, 2024 07:00AM Mind Medicine (MNMD) Issued New Patent for MM120

Jun 28, 2024 07:39AM Mind Medicine (MNMD) Files Mixed Shelf

Jun 20, 2024 07:03AM Mind Medicine (MNMD) Announces Constructive End-of-Phase 2 Meeting with FDA for MM120